Bloomberg News

Diagenic Says Early Results for Early Alzheimer Tests Positive

October 14, 2011

Oct. 14 (Bloomberg) -- DiaGenic ASA said the preliminary findings from the collaborative R&D project with Pfizer Inc. where the objective was to identify blood-based biomarkers that may be useful in diagnosing and monitoring of Alzheimer’s Disease were positive.

Link to Statement:{NSN LT1MZN3HBS3L <GO>}

To contact the editor responsible for this story: Marianne Stigset at mstigset@bloomberg.net


Tim Cook's Reboot
LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus